Endotronix

📍 Lisle, United States🗓 Founded 2007👥 125 employees💰 Last funded Sep 2018
Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.
7
Total investors
0
Early stage
1
Mid stage
4
Late stage
2007
Founded
Investor geography2 countries
United States
6
Germany
1
Investor activity2012–2018 · investors recorded per year
201212016420182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Endotronix?
Endotronix has 7 investors on record on gritt.io, 1 mid-stage and 4 late-stage investors.
When did Endotronix last raise funding?
The most recent investment in Endotronix recorded on gritt.io was in September 2018.
When was Endotronix founded?
Endotronix was founded in 2007.
What industry is Endotronix in?
Endotronix operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Endotronix based?
Endotronix is headquartered in Lisle, United States.